| Medical and Health Sciences | Lifetime | 86 | US 48 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 480 | US 165 | 99.90 |
| Cardiology and Cardiovascular Medicine | Lifetime | 16 | US 13 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 185 | US 100 | 99.45 |
| Public, Environmental and Occupational Health | Lifetime | 806 | US 416 | 98.85 |
| Nutrition and Dietetics | Lifetime | 607 | US 250 | 97.25 |
| Complementary and Alternative Medicine | Lifetime | 466 | US 167 | 97.07 |
| Rheumatology | Lifetime | 727 | US 330 | 96.30 |
| Nephrology | Lifetime | 505 | US 241 | 94.70 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 51 | US 31 | 99.81 |
| Nephrology | 2021-2025 | 187 | US 70 | 91.17 |
| Medical Physiology | 2021-2025 | 825 | US 296 | 86.32 |
| Genetics | 2021-2025 | 564 | US 209 | 84.09 |
| Complementary and Alternative Medicine | 2021-2025 | 196 | US 49 | 84.27 |
| Cardiovascular Disease and Adiposity | Lifetime | 1 | US 1 | 99.96 |
| Cardiovascular Function and Risk Factors | Lifetime | 7 | US 7 | 99.98 |
| Cardiovascular Health and Disease Prevention | Lifetime | 4 | US 1 | 99.92 |
| Blood Pressure and Hypertension Studies | Lifetime | 9 | US 4 | 99.93 |
| Cardiovascular Health and Risk Factors | Lifetime | 2 | US 1 | 99.94 |
| Heart Failure Treatment and Management | Lifetime | 31 | US 20 | 99.88 |
| Lipoproteins and Cardiovascular Health | Lifetime | 76 | US 46 | 99.55 |
| GDF15 and Related Biomarkers | Lifetime | 9 | US 4 | 99.05 |
| Heart Rate Variability and Autonomic Control | Lifetime | 123 | US 54 | 99.35 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 100 | US 43 | 99.54 |
| Sodium Intake and Health | Lifetime | 37 | US 20 | 99.11 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 170 | US 78 | 99.10 |
| Cardiac Imaging and Diagnostics | Lifetime | 410 | US 219 | 99.31 |
| Genetic Associations and Epidemiology | Lifetime | 139 | US 66 | 99.08 |
| Nutritional Studies and Diet | Lifetime | 241 | US 106 | 99.07 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 404 | US 170 | 98.98 |
| Hormonal Regulation and Hypertension | Lifetime | 308 | US 132 | 98.45 |
| Cardiac Valve Diseases and Treatments | Lifetime | 567 | US 287 | 98.88 |
| Adipose Tissue and Metabolism | Lifetime | 814 | US 370 | 98.13 |
| Cardiac Health and Mental Health | Lifetime | 271 | US 153 | 97.97 |
| Folate and B Vitamins Research | Lifetime | 375 | US 192 | 97.06 |
| Biomarkers in Disease Mechanisms | Lifetime | 81 | US 23 | 96.35 |
| Diet, Metabolism, and Disease | Lifetime | 546 | US 199 | 97.42 |
| Birth, Development, and Health | Lifetime | 945 | US 364 | 97.65 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 687 | US 270 | 96.96 |
| Cardiac pacing and defibrillation studies | Lifetime | 733 | US 377 | 97.89 |
| Cardiovascular and exercise physiology | Lifetime | 644 | US 232 | 97.40 |
| Chronic Kidney Disease and Diabetes | Lifetime | 421 | US 176 | 97.75 |
| Cardiovascular Effects of Exercise | Lifetime | 513 | US 225 | 97.21 |
| Apelin-related biomedical research | Lifetime | 165 | US 59 | 95.25 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 168 | US 41 | 96.06 |
| Cardiac Fibrosis and Remodeling | Lifetime | 288 | US 112 | 95.93 |
| Protease and Inhibitor Mechanisms | Lifetime | 814 | US 340 | 95.70 |
| Health, Environment, Cognitive Aging | Lifetime | 405 | US 202 | 94.67 |
| Lipid metabolism and disorders | Lifetime | 477 | US 183 | 95.20 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 895 | US 333 | 94.96 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 337 | US 89 | 93.89 |
| Heart rate and cardiovascular health | Lifetime | 181 | US 57 | 88.73 |
| Aortic Thrombus and Embolism | Lifetime | 587 | US 221 | 70.56 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 5 | US 2 | 99.58 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 18 | US 6 | 99.54 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 10 | US 7 | 99.11 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 28 | US 13 | 97.97 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 136 | US 64 | 99.03 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 112 | US 40 | 96.86 |
| Heart Failure Treatment and Management | 2021-2025 | 227 | US 87 | 97.28 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 299 | US 88 | 93.68 |
| Genetic Associations and Epidemiology | 2021-2025 | 321 | US 149 | 93.81 |
| Cardiac Health and Mental Health | 2021-2025 | 366 | US 128 | 90.39 |
| GDF15 and Related Biomarkers | 2021-2025 | 83 | US 20 | 84.62 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 884 | US 248 | 86.31 |
| Fatty Acid Research and Health | 2021-2025 | 576 | US 114 | 76.22 |
| Nutrition, Genetics, and Disease | 2021-2025 | 762 | US 189 | 71.11 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 758 | US 129 | 50.48 |
| Protein Tyrosine Phosphatases | 2021-2025 | 744 | US 221 | 43.57 |
